دورية أكاديمية
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multi Criteria Decision Analysis.
| العنوان: | Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multi Criteria Decision Analysis. |
|---|---|
| المؤلفون: | Barbhaiya M; Hospital for Special Surgery; Weill Cornell Medicine, New York, NY, USA., Zuily S; CHRU-Nancy, Nancy University Hospital; INSERM UMR-S 1116; University of Lorraine, F-54000, Nancy, France., Amigo MC; ABC Medical Center, Mexico DF, Mexico., Andrade D; University of Sao Paulo, Sao Paulo, Brazil., Avcin T; Rheumatology, and Clinical Immunology, Children's Hospital, University Medical Center, University of Ljubljana, Ljubljana, Slovenia., Bertolaccini ML; King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, UK., Branch DW; University of Utah Health, Salt Lake City, UT, USA., Costedoat-Chalumeau N; APHP, Hopital Cochin; Université de Paris, Centre de recherche épidémiologie et biostatistiques de Sorbonne Paris Cité, F-75004, Paris, France., Crowther M; McMaster University, Canada., de Jesus GR; Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil., Devreese KMJ; Ghent University Hospital, Ghent University, Ghent, Belgium., Frances C; Tenon Hospital, Paris, France., Garcia D; University of Washington, Seattle, WA, USA., Gómez-Puerta JA; Hospital Clinic and IDIBAPS, Barcelona, Spain., Guillemin F; CHRU, Inserm, Université de Lorraine, and INSPIIRE, Université de Lorraine, Inserm, Nancy, France., Levine SR; State University of New York Downstate Health Sciences University; Kings County Hospital Center, and Maimonides Medical Center/Jaffe Stroke Center, Brooklyn, NY, USA., Levy RA; Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil; and Glaxo Smith Kline, Upper Providence, PA, USA., Lockshin MD; Hospital for Special Surgery; Weill Cornell Medicine, New York, NY, USA., Ortel TL; Duke University School of Medicine, Durham, NC, USA., Petri M; Hopkins University School of Medicine, Baltimore, MD, USA., Sanna G; Guy's and St Thomas' NHS Foundation Trust, London, UK., Sciascia S; S. Giovanni Bosco Hospital, Turin, Italy., University of Turin, Torino, Italy., Seshan SV; Weill Cornell Medicine, New York, New York, USA., Tektonidou MG; National and Kapodistrian, University of Athens, Athens, Greece., Wahl D; CHRU-Nancy, Nancy University Hospital; INSERM UMR-S 1116; University of Lorraine, F-54000, Nancy, France., Willis R; Antiphospholipid Standardization Laboratory, University of Texas Medical Branch, Galveston, TX, USA., Yelnik C; Univ. Lille, CHU Lille, INSERM, UMR 1167, F-59000, Lille, France., Hendry A; Middlemore Hospital, Auckland, New Zealand., Naden R; Auckland City Hospital, Auckland, New Zealand., Costenbader K; Brigham and Women's Hospital, Boston, MA, USA., Erkan D; Hospital for Special Surgery; Weill Cornell Medicine, New York, NY, USA. |
| مؤلفون مشاركون: | New APS Classification Criteria Collaborators |
| المصدر: | Arthritis care & research [Arthritis Care Res (Hoboken)] 2024 Aug 12. Date of Electronic Publication: 2024 Aug 12. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2151-4658 (Electronic) Linking ISSN: 2151464X NLM ISO Abbreviation: Arthritis Care Res (Hoboken) Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Hoboken, NJ : John Wiley & Sons |
| مستخلص: | Background: The 2023 ACR/EULAR Antiphospholipid Syndrome (APS) Classification Criteria development, aiming to identify patients with high likelihood of APS for research, employed a four-phase methodology. Phase I and II resulted in 27 proposed candidate criteria, organized into laboratory and clinical domains. Here, we summarize the last stage of Phase III efforts employing a consensus-based multi-criteria decision analysis (MCDA) to weigh candidate criteria and identify an APS classification threshold score. Methods: We evaluated 192 unique, international real-world cases referred for "suspected APS" with a wide range of APS manifestations. Using proposed candidate criteria, subcommittee members rank-ordered 20 representative cases from highly unlikely to highly likely APS. During an in-person meeting, the subcommittee refined definitions and participated in an MCDA exercise to identify relative weights of candidate criteria. Using consensus decisions and pairwise criteria comparisons, 1000Minds™ software assigned criteria weights, and we rank ordered 192 cases by their additive scores. A consensus-based threshold score for APS classification was set. Results: Pre-meeting evaluation of 20 representative cases demonstrated variability in APS assessment. MCDA resolved 81 pairwise decisions; relative weights identified domain item hierarchy. After assessing 192 cases by weights and additive scores, the Steering Committee reached consensus that APS classification should require separate clinical and laboratory scores, rather than a single aggregate score, to ensure high specificity. Conclusion: Using MCDA, candidate criteria preliminary weights were determined. Unlike other disease classification systems using a single aggregate threshold score, separate clinical and laboratory domain thresholds were incorporated into the new APS classification criteria. (This article is protected by copyright. All rights reserved.) |
| فهرسة مساهمة: | Investigator: N Agmon-Levin; C Aguilar; P Alba; O Alpan; A Ambrozic; L Andrade; S Appenzeller; Y Berkun; A Cabral; G Canaud; P Chen; C Chighizola; R Cimaz; MJ Cuadrado; PG de Groot; P de Moerloose; R Derksen; T Dörner; P Fortin; B Giannakopoulos; EB Gonzalez; M Inanc; G Kenet; M Khamashta; M Kriegel; S Krilis; D Ladha; F Manneville; P Massicotte; G McCarty; J Mikdashi; B Myones; L Sammaritano; F Signorelli; A Soybilgic; S Woller; R Zuo |
| تواريخ الأحداث: | Date Created: 20240813 Latest Revision: 20240813 |
| رمز التحديث: | 20240813 |
| DOI: | 10.1002/acr.25415 |
| PMID: | 39135467 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2151-4658 |
|---|---|
| DOI: | 10.1002/acr.25415 |